Bio-En Holdings Corp (BENH)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | 3923.00 | 15.32 Thousand | -349.44 Thousand | -196.73 Thousand | 13.07 Thousand |
| Net Income | - | -41.83 Thousand | -255.04 Thousand | -126.15 Thousand | -88.38 Thousand | 308.68 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 45.76 Thousand | 270.37 Thousand | -223.28 Thousand | -108.35 Thousand | -242.03 Thousand |
| Other non-cash items | - | -15 Thousand | -226.1 Thousand | 234.88 Thousand | 6220.00 | -53.57 Thousand |
| Investing Cash Flow | - | - | - | - | 236.25 Thousand | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 236.25 Thousand | - |
| Financing Cash Flow | - | - | -4037.00 | 344.44 Thousand | -34.15 Thousand | -14.15 Thousand |
| Debt repayment | - | - | -4037.00 | -344.44 Thousand | -34.15 Thousand | -14.15 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -4.04 | 688.88 Thousand | 202.09 Thousand | -14.15 Thousand |
| Accounts receivables | - | 15 Thousand | 226.1 Thousand | -234.88 Thousand | -6220.00 | - |
| Accounts payables | - | 30.76 Thousand | 44.27 Thousand | 11.59 Thousand | -102.13 Thousand | -242.03 Thousand |
| Inventory | - | -15 Thousand | -226.1 Thousand | 234.88 Thousand | - | - |
| Other working capital | - | 15 Thousand | 226.1 Thousand | -234.88 Thousand | -6220.00 | -242.03 Thousand |
| Cash at beginning of period | 15.63 Thousand | 11.71 Thousand | 420.00 | 5420.00 | 60.00 | 1136.00 |
| Cash at end of period | 15.63 Thousand | 15.63 Thousand | 11.71 Thousand | 420.00 | 5420.00 | 60.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 3923.00 | 11.29 Thousand | -5000.00 | 5360.00 | -1076.00 |
| Free Cash Flow | - | 3923.00 | 15.32 Thousand | -349.44 Thousand | -196.73 Thousand | 13.07 Thousand |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | -16.45 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | 16.45 Thousand |
| Other non-cash items | - | - | - | - | - | 16.46 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | 16.45 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | - | 15.63 Thousand | 1679.00 | 1679.00 |
| Cash at end of period | - | - | - | 15.63 Thousand | 1679.00 | 1679.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | 16.46 |
2115
AWZ
601126
8013
1459
ADAP